Trial
NCT01773616
Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Phase IIITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
Karolinska Institutet; Ohio State University; Dutch Working Party on Systemic Lupus Erythematosus; EULAR Lupus Nephritis Trial Network Study Group
Condition
Systemic Lupus Erythematosus, Lupus Nephritis
Intervention
Oral prednisolone
Why stopped
Study assessments for patients recruited continuing per protocol so patients receive a minimum of 6 months follow up. No safety concerns have been raised.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-02-01